The hispanic landscape of triple negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous and complex disease
characterized by the absence of immunohistochemical expression of estrogen receptor …
characterized by the absence of immunohistochemical expression of estrogen receptor …
Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco
J Bakkach, M Mansouri, T Derkaoui, A Loudiyi… - BMC cancer, 2020 - Springer
Background To date, the contribution of BRCA1/2 mutations in Moroccan early onset breast
cancer patients remains unknown. Here we assess these genetic alterations for the first time …
cancer patients remains unknown. Here we assess these genetic alterations for the first time …
[Retracted] Expression of PD‐L1 and BRCA1 in Triple‐Negative Breast Cancer Patients and Relationship with Clinicopathological Characteristics
X Huang, X Wang, H Qian, X Jin… - … and Alternative Medicine, 2021 - Wiley Online Library
Objective. To study the expression of programmed cell death ligand‐1 (PD‐L1) and breast
cancer susceptibility gene 1 (BRCA1) in triple‐negative breast cancer (TNBC) patients and …
cancer susceptibility gene 1 (BRCA1) in triple‐negative breast cancer (TNBC) patients and …
Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region
SC Elalaoui, FZ Laarabi, L Afif, J Lyahyai… - Breast Cancer Research …, 2022 - Springer
Purpose Breast cancer (BC) is the most common form of female cancer around the world.
BC is mostly sporadic, and rarely hereditary. These hereditary forms are mostly BRCA1-and …
BC is mostly sporadic, and rarely hereditary. These hereditary forms are mostly BRCA1-and …
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
RQ Li, L Yan, L Zhang, HX Ma, HW Wang, P Bu… - Scientific Reports, 2024 - nature.com
Triple-negative breast cancer (TNBC) has high heterogeneity, poor prognosis, and limited
treatment success. Recently, an immunohistochemistry-based surrogate classification for the …
treatment success. Recently, an immunohistochemistry-based surrogate classification for the …
Clinicopathological, treatment and event-free survival characteristics in a moroccan population of triple-negative breast cancer
Introduction: Triple-negative breast cancer (TNBC) is a group of breast carcinoma
characterized by the lack of expression of estrogen and progesterone hormone receptors …
characterized by the lack of expression of estrogen and progesterone hormone receptors …
[HTML][HTML] Identification of a novel pathogenic variant in PALB2 and BARD1 genes by a multigene sequencing panel in triple negative breast cancer in Morocco
A Laraqui, M Cavaillé, N Uhrhammer, O ElBiad… - Journal of …, 2021 - ncbi.nlm.nih.gov
Pathogenic variants (PVs) in BRCA genes have been mainly associated with an increasing
risk of triple negative breast cancer (TNBC). The contribution of PVs in non-BRCA genes to …
risk of triple negative breast cancer (TNBC). The contribution of PVs in non-BRCA genes to …
Screening of BRCA1 and BRCA2 germline mutations in unselected triple‐negative breast cancer patients: A series from north of Morocco
M Mansouri, T Derkaoui, J Bakkach… - Precision Medical …, 2020 - Wiley Online Library
Background Triple‐negative breast cancer (TNBC) is strongly associated with BRCA1 and
BRCA2 germline pathogenic variants. Revised NCCN guidelines recommend that TNBC …
BRCA2 germline pathogenic variants. Revised NCCN guidelines recommend that TNBC …
[HTML][HTML] Molecular subtypes and clinicopathological features of breast cancer in Libya: a first glance
A Abousahmeen, MAB Saud, S Elrais… - Therapeutic …, 2023 - tro.amegroups.org
Background: Breast cancer (BC) is the most frequent malignancy among Libyan women.
Immunohistochemistry (IHC) markers for estrogen receptor (ER), progesterone receptor …
Immunohistochemistry (IHC) markers for estrogen receptor (ER), progesterone receptor …
Association of vitamin D deficiency and insulin resistance with breast cancer in premenopausal Algerian women: A cross-sectional study
RI Mehaoudi, S Adane, M Sadouki, A Melboucy… - Annales d' …, 2021 - Elsevier
Abstract Background Low 25 (OH) D levels are mainly related to breast cancer (BC) risk in
postmenopausal women, while the impact of insulin resistance (IR) on BC prognosis is …
postmenopausal women, while the impact of insulin resistance (IR) on BC prognosis is …